Journal article Published 2022

Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors

Jiří Řehulka, I. Subtelna, Anna Kryshchyshyn-Dylevych, A. Cherniienko, A. S. Ivanova, Mariia Matveieva, Pavlo Polishchuk, Soňa Gurská, Marián Hajdúch, O. Zagrijtchuk, Petr Džubák, R. Lesyk

Archiv der Pharmazie 355(12), e2200419 (2022)

View on PubMed Cite

2022 Year
36109178 PMID

Cite this publication

ŘEHULKA, J., I. SUBTELNA, A. KRYSHCHYSHYN-DYLEVYCH, A. CHERNIIENKO, A. IVANOVA, M. MATVEIEVA, P. POLISHCHUK, S. GURSKÁ, M. HAJDÚCH, O. ZAGRIJTCHUK, P. DŽUBÁK, R. LESYK: Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors. Archiv der Pharmazie. 2022, 355(12), e2200419, ISSN: 0365-6233, PMID: 36109178.

Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors

Cite this publication

Details

Authors from EATRIS